Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 30517
Assessing Psycho-Social Stressors for Chronically Infected Hepatitis C Virus Patients in Egypt

Authors: Ammal M. Metwally, Walaa A. Fouad, Dalia M. Elmosalami, Abla G. Khalifa, Lobna A. El Etreby, Mohamed AbdelRahman


People with hepatitis C are likely to experience psychological distress related to adjustment issues following diagnosis. Objective: The study was conducted to determine the psycho-social stressors accompanying Hepatitis C virus (HCV) chronic infection. The study focused on immediate and later on reactions to being diagnosed as infected HCV patients. Effect of HCV on disruption of patients’ relationships in term of family relationship and friendship, employment and financial status was assessed. The magnitude and causes of the social stigma and its relation to awareness about illness, level of education were also assessed. Methods: During this study the subjective experiences of people having HCV was explored through a designed questionnaire targeted 540 cases; 359 males and 181 females from ten out of 21 National Treatment Reference Centers of National Hepatology and Tropical Medicine Research Institutes of Ministry of Health (MOH) hospitals. The study was conducted along a period of six months from September 2011 to March 2012. Results: The study revealed that the financial problems are the commonest problems faced by 75.5% of the cases. More than 70% of the cases suffered from immediate sadness versus 67.4% suffered from worry. Social stigma was reported by 13 % of HCV +patients, the majority of which were females. Conclusions: Exploring the psychosocial consequences of HCV infection can act as pressing motivators for behavior change needed for limiting HCV endemicity in Egypt.

Keywords: Egypt, HCV infection, stigma, psychosocial adjustment

Digital Object Identifier (DOI):

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1707


[1] World Health Organization Initiative for Vaccine Research (2007): Hepatitis C. diseases/hepatitis_c/en/
[2] Anonymous (1999): Hepatitis C-global prevalence. WklyEpidemiol Rec.; 74: 425–7.
[3] Xia X., Luo J., Bai J. and Yu R. (2008): Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health; 122: 990–1003.
[4] El-Zayadi A. (2009): Hepatitis C comorbidities affecting the course and response to therapy World Gasteroenterol.; 15: 4993–4999.
[5] Mohamed M.. (2004): Epidemiology of HCV in Egypt. The Afro-Arab Liver Journal; 3(2): 41-52.
[6] Weinbaum C., Lyerla R. and Margolis S. (2003): Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. MMWR Recomm Rep.; 52: 1–36.
[7] Lucinda K. (2012): Women and hepatitis C. Hepatitis C Support Project / HCV.
[8] Barkhuizen A., Rosen H., Wolf S., Flora K., Benner K. and Bennett R. (2001): Musculoskeletal pain and fatigue are associated with chronic hepatitis C: A report of 239 hepatology clinic patients. Am J Gastroenterol. 1999; 94:1355–60.
[9] Obhrai J., Hall Y. and Anand B. (1998): Assessment of fatigue and psychologic disturbances in patients with hepatitis C virus infection. J Clin Gastroenterol.; 32: 413–7.
[10] Yates W. and Gleason O. (2000): Hepatitis C and depression. Depress Anxiety.; 7: 188–93.
[11] Foster G., Goldin R. and Thomas H. (1998): Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology.; 27:209–12.
[12] Chong C., Gulamhussein A., Heathcote E. (2003): Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol.; 98:630–8.
[13] Dwight M., Kowdley K., Russo J., Ciechanowski P., Larson A. and Katon W. (2000): Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res.; 49:311–7.
[14] Lee H., Jamal H., Regenstein F. and Perrillo R. (1997): Morbidity of chronic hepatitis C as seen in a tertiary care medical center. Dig Dis Sci.; 42: 186–91.
[15] Gallegos-Orozco J. F., Fuentes A. P. and Gerardo Argueta J. (2003): Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res.; 34: 124–9.
[16] Goulding C., O’Connell P. and Murray F.. (2001): Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: Relationship to RT-PCR status and mode of acquisition. Eur J Gastroenterol Hepatol.; 13:507–11.
[17] Cornberg M., Wedmeyer H. and Manns M. (2002): Treatment of chronic hepatitis C with pegylated interferon and ribaverin Curr Gastroenterol Rep.; 4:23–30.
[18] Crockett B. and Gifford S. (2004): "Eyes Wide Shut”: narratives of women living with hepatitis C in Australia. Women Health.; 39(4):117–137.
[19] Zickmund S., Ho E., Masuda M., Ippolito L. and LaBrecque D. (2003):"They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis.J Gen Intern Med: 18(10):835-844.
[20] Lucinda K. (2010): Hepatitis c and stigma. Hepatitis C Support Project / HCV.
[21] Ward, J., Coleborne, M., and Fort, T. (2000): Hepatitis C and discrimination. Canberra: Commonwealth Department of Health and Aged Care, Australia.
[22] Loveday S., Treloar C., Elek, C., Steele M. and Hopwood M. (2005): Discrimination and hepatitis C. In J. Godwin, D. Puls, J. Cabassi, L. Crooks & M. Carman (Eds.), HIV and hepatitis C: Policy, discrimination, legal and ethical issues (pp. 43–56). Sydney: Australasian Society for HIV Medicine Inc.
[23] Anti-Discrimination Board of New South Wales. (2001): C change: The report of the enquiry into hepatitis C related discrimination. Sydney: ADB NSW. adb_hepatitis_c_enquiry.
[24] Blasiole J., Shinkunas L., Labrecque D., Arnold R. and Zickmund S. (2006): Mental and physical symptoms associated with lower social support for patients with hepatitis C. World J Gastroenterol.; 12(29): 4665– 4672.
[25] Zickmund S., Hillis S., Barnett M., Ippolito L., LaBrecque D. (2004): Hepatitis C virus-infected patients report communication problems with physicians. Hepatology.; 39(4):999–1007.
[26] Cormier M. (2005): The role of hepatitis C support groups. Gastroenterol Nurs; 28: S4-9.
[27] Cronan T., Groessl E. and Kaplan R. (1997): The effects of social support and education interventions on health care costs. Arthritis Care Res.;10(2):99–110.
[28] Lorig K., Ritter P. and Stewart A. (2001): Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care.; 39(11):1217–1223.
[29] Lorig K., Ritter P., and Gonzalez V. (2003): Hispanic chronic disease self-management: a randomized community-based outcome trial. Nurs Res.; 52(6):361–369.
[30] Groessl E. and Cronan T. (2000): A cost analysis of self-management programs for people with chronic illness. Am J Community Psychol.; 28(4): 455–480.
[31] Cronan T., Hay M., Groessl E., Bigatti S., Gallagher R. and Tomita M. (1998): The effects of social support and education on health care costs after three years. Arthritis Care Res.; 11(5):326–334.
[32] Myra S., Louise O. and Debra J. (2008): Living with hepatitis C and treatment: the personal experiences of patients. Journal of Clinical Nursing.; 18: 2282–91.
[33] Martin L. (2008): Socio-Demographic, Clinical, And Social Influences On Health-Related Quality Of Life In Individuals With Hepatitis C (Hcv). Ph.D. Case Western Reserve University.
[34] Erik J., Kimberly R. and Robert M. (2008): Living with Hepatitis C: Qualitative Interviews with Hepatitis C-infected Veterans. J Gen Intern Med.; 23(12): 1959–1965.
[35] Glacken M.., Kernohan G. and Coates V. (2001): Diagnosed with Hepatitis C: adescriptive exploratory study. Int J Nurs Stud.; 38(1):107–116. Feb
[36] Tompkins C, Wright N, Jones L. (2005): Impact of a positive hepatitis C diagnosis on homeless injecting drug users: a qualitative study. Br J Gen Pract.; 55 (513):263–268.
[37] Fontana R., Hussain K. and Schwartz S. (2002): Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol.; 36(3): 401-7.
[38] Elshahawi H., Hussein M. and Allam A. (2011): Depression comorbidity in patients with chronic hepatitis C and its possible relation to treatment outcome. Middle East Current Psychiatry: 18: p 23–28.
[39] Amy J. , Sarahaw M., Liana F. and Guadalupe G. (2008): Psychosocial Correlates of Hepatitis C. Interaction and impact on quality of life; Psychosomatics. –Dec; 49(6): 494–501.
[40] Kadushin G. (1996): Gay men with AIDS and their families of origin: an analysis of social support. Health Soc Work; 21: 141-149.
[41] Kelly P. (1999): Isolation and stigma: the experience of patients with active tuberculosis. J Community Health Nurs; 16: 233-241.
[42] Julie A., Laura S. and Douglas R. (2006): Mental and physical symptoms associated with lower social support for patients with hepatitis C. World J Gastroenterol 2006 August 7; 12(29): 4665-4672.
[43] Conrad S. and Garrett L. (2006): Living with chronic hepatitis C means 'you just haven't got a normal life any more', Chronic Illness.
[44] Glacken M., Coates V., Kernohan G. and Hegarty J. (2003): The experience of fatigue for people living with hepatitis C. J Clin Nurs.; 12(2):244– 252.
[45] Spiegel B., Younossi Z., Hays R., Revicki D., Robbins S. and Kanwal F. (2005): Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology.; 41(4):790–800. /
[46] Strauss E. and Dias Teixeira M. (2006): Quality of life in hepatitis C. Liver Int.; 26(7):755–765.
[47] Sean R. (2012): Canada - Financial stress—impact on HIV adherence, HCV, and prescribing patterns; North America HIV News.
[48] Minuk G., Gutkin A., Wong S. and Kaita K. (2005): Patient concerns regarding chronic hepatitis C infections. J Viral Hepat; 12: 51-57.
[49] Crofts N., Louie R. and Loff B. (1997): The next plague: stigmatization and 4670 ISSN 1007-9327 CN 14-1219/ R World J Gastroenterol August 7, 2006 Volume 12 Number 29 discrimination related to hepatitis C virus infection in Australia. Health Hum Rights; 2: 87-97.
[50] Banwell C., Bammer G., Gifford S. and O’Brien M. (2005): Australian lesbian and bisexual women‘s health and social experiences of living with hepatitis C. Health Care Women Int; 26: 340-354. The three most common perceived reasons for stigma were society’s association of hepatitis C virus with HIV/AIDS, the attribution of promiscuity, and the assumption that the person with hepatitis C was an injecting drug user.
[51] Chao S., Chang E. and So S. (2009): Eliminating the threat of chronic hepatitis B in the Asian and Pacific Islander community: A call to action. Asian Pac J Cancer Prev.; 10(3): 497-512.
[52] Marc G., Ghany K., Doris B., Strader S., David L., Thomas L., et al. (2009): Understanding and Implementing the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines on the Diagnosis, Management, and Treatment of Hepatitis C. AnUpdate. Hepatology.; 49(4): 335-73.